Percepción de la insulinoterapia en pacientes con diabetes mellitus tipo 2 descontrolada / Perception of insulin therapy in uncontrolled patients with type 2 diabetes mellitus

OBJETIVO: Conocer la percepción de la insulinoterapia en los pacientes con diabetes mellitus tipo 2 descontrolada tratados con hipoglucemiantes orales o con insulina. DISEÑO: Transversal comparativo prospectivo. Emplazamiento: Unidad de Medicina Familiar número 53 de la Delegación Guanajuato del Instituto Mexicano del Seguro Social. PARTICIPANTES: Pacientes de 40 a 80 años afectos de diabetes tipo 2, descontrolados, en tratamiento con insulina o hipoglucemiantes orales. MEDICIONES PRINCIPALES: La percepción se evaluó con la escala de percepción del tratamiento de insulina (Insulin Treatment Appraisal Scale [ITAS]). La calificación de la encuesta es de 20 a 100 puntos, de tal manera que cuanto mayor es la puntuación, mayor es la opinión negativa. RESULTADOS: Se encuestaron 459 pacientes, 261 (56,9%) tratados con hipoglucemiantes orales (HO) y 198 (43,1%) con insulina sola o combinada con hipoglucemiantes orales (IN). La calificación global de la percepción del tratamiento con insulina fue de 56,95 ± 7,78 en el grupo HO y de 49,55 ± 8,89 en el grupo IN (p < 0,001). CONCLUSIONES: La percepción de la insulinoterapia es más negativa en los sujetos que usan hipoglucemiantes orales que en los que usan insulina

OBJECTIVE: To determine the perception of insulin therapy by patients with uncontrolled type 2 diabetes mellitus, who have been treated with oral hypoglycaemic agents or insulin. DESIGN: Prospective comparative cross-sectional study. SETTING: Family Medicine Unit No.53 León, Guanajuato of Mexican Institute of Social Security. PARTICIPANTS: Patients between 40 and 80 years old with uncontrolled type 2 mellitus diabetes, treated with insulin or oral hypoglycaemic agents. MAIN MEASUREMENTS: Perception was assessed using the insulin treatment appraisal scale (ITAS). The rating of the survey is from 20 to 100 points, as such that when score increases the greater is the negative opinion. RESULTS: A sample of 459 diabetes patients were interviewed and split into 2 groups of patients according to their treatment. The OH group were patients treated with oral hypoglycaemic drugs only (56.9%), and the IN group were patients treated with insulin alone or combined with an oral hypoglycaemic (43.1%). Perception score was significantly higher in OH group (56.95 ± 7.78 versus 49.55 ± 8.89 points) than in the IN group (P <.001). CONCLUSIONS: The perception of insulin therapy was worse in patients treated with only oral hypoglycaemic agents than in patients using insulin

[Perception of insulin therapy in uncontrolled patients with type 2 diabetes mellitus]. / Percepción de la insulinoterapia en pacientes con diabetes mellitus tipo 2 descontrolada.

OBJECTIVE: To determine the perception of insulin therapy by patients with uncontrolled type2 diabetes mellitus, who have been treated with oral hypoglycaemic agents or insulin. DESIGN: Prospective comparative cross-sectional study. SETTING: Family Medicine Unit No. 53 León, Guanajuato of Mexican Institute of Social Security. PARTICIPANTS: Patients between 40 and 80years old with uncontrolled type2 mellitus diabetes, treated with insulin or oral hypoglycaemic agents. MAIN MEASUREMENTS: Perception was assessed using the insulin treatment appraisal scale (ITAS). The rating of the survey is from 20 to 100 points, as such that when score increases the greater is the negative opinion. RESULTS: A sample of 459 diabetes patients were interviewed and split into 2 groups of patients according to their treatment. The OH group were patients treated with oral hypoglycaemic drugs only (56.9%), and the IN group were patients treated with insulin alone or combined with an oral hypoglycaemic (43.1%). Perception score was significantly higher in OH group (56.95±7.78 versus 49.55±8.89 points) than in the IN group (P<.001). CONCLUSIONS: The perception of insulin therapy was worse in patients treated with only oral hypoglycaemic agents than in patients using insulin.